201. Production and purification of bovine monocyte-derived interleukin 1
- Author
-
Charles J. Czuprynski and James A. Lederer
- Subjects
Lipopolysaccharides ,Lipopolysaccharide ,Immunology ,Biology ,In Vitro Techniques ,medicine.disease_cause ,Monocytes ,chemistry.chemical_compound ,medicine ,Animals ,Escherichia coli ,Chromatography, High Pressure Liquid ,General Veterinary ,Monocyte ,Interleukin ,Biological activity ,Molecular biology ,In vitro ,Culture Media ,Molecular Weight ,Thymocyte ,medicine.anatomical_structure ,Biochemistry ,chemistry ,Cattle ,Female ,Fetal bovine serum ,Interleukin-1 - Abstract
Few studies have addressed the biological and molecular nature of bovine interleukin 1 (IL-1). In an effort to increase our understanding of the role of bovine IL-1 in bovine immunology, we investigated various parameters of its production by LPS-stimulated monocytes in vitro. Bovine monocytes isolated by our methods constitutively released IL-1 activity, as measured by the murine thymocyte IL-1 assay. Monocyte release of IL-1 activity was further augmented when the cells were incubated with 0.005–10 μg per ml of Escherichia coli lipopolysaccharide (LPS). The presence of 1, 5, or 10 percent heat-inactivated fetal bovine serum (FBS) enhanced LPS-stimulated bovine monocyte release of IL-1 activity as compared with monocytes cultured under serum-free conditions. We used a combination of size-exclusion and reverse-phase high-performance liquid chromatography (HPLC) to purify bovine IL-1 from serum-free monocyte culture supernatants. Size-exclusion HPLC resulted in a single peak of biological activity with an approximate molecular weight of 18 000 daltons. Further purification by reverse-phase HPLC demonstrated at least three major molecular species with IL-1 activity. Besides providing information about production of IL-1 by bovine monocytes in vitro, this study also describes a protocol to purify bovine IL-1 for future studies addressing its biological functions.
- Published
- 1989